DK0892802T3 - Spiro[cyclopent[b]indol-piperidiner] og N-phenyl-hydrazon-mellemprodukter til deres fremstilling, begge som acetylcholinesterase- og mao-inhibitorer - Google Patents

Spiro[cyclopent[b]indol-piperidiner] og N-phenyl-hydrazon-mellemprodukter til deres fremstilling, begge som acetylcholinesterase- og mao-inhibitorer

Info

Publication number
DK0892802T3
DK0892802T3 DK97908068T DK97908068T DK0892802T3 DK 0892802 T3 DK0892802 T3 DK 0892802T3 DK 97908068 T DK97908068 T DK 97908068T DK 97908068 T DK97908068 T DK 97908068T DK 0892802 T3 DK0892802 T3 DK 0892802T3
Authority
DK
Denmark
Prior art keywords
cyclopent
acetylcholinesterase
piperidines
spiro
indole
Prior art date
Application number
DK97908068T
Other languages
Danish (da)
English (en)
Inventor
Gerard J O'malley
Mark G Palermo
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Application granted granted Critical
Publication of DK0892802T3 publication Critical patent/DK0892802T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DK97908068T 1996-04-10 1997-03-10 Spiro[cyclopent[b]indol-piperidiner] og N-phenyl-hydrazon-mellemprodukter til deres fremstilling, begge som acetylcholinesterase- og mao-inhibitorer DK0892802T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63064196A 1996-04-10 1996-04-10
PCT/US1997/003864 WO1997037992A2 (en) 1996-04-10 1997-03-10 Spiro[cyclopent[b]indole-piperidines] and n-phenyl-hydrazon intermediates for their preparation, both being acetylcholinesterase and mao inhibitors

Publications (1)

Publication Number Publication Date
DK0892802T3 true DK0892802T3 (da) 2003-12-01

Family

ID=24527997

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97908068T DK0892802T3 (da) 1996-04-10 1997-03-10 Spiro[cyclopent[b]indol-piperidiner] og N-phenyl-hydrazon-mellemprodukter til deres fremstilling, begge som acetylcholinesterase- og mao-inhibitorer

Country Status (18)

Country Link
EP (1) EP0892802B1 (de)
JP (1) JP3615225B2 (de)
KR (1) KR100270145B1 (de)
CN (1) CN1233249A (de)
AR (1) AR006553A1 (de)
AT (1) ATE252581T1 (de)
AU (1) AU708124B2 (de)
BR (1) BR9708563A (de)
CA (1) CA2251545C (de)
DE (1) DE69725713T2 (de)
DK (1) DK0892802T3 (de)
ES (1) ES2207718T3 (de)
HU (1) HUP9902755A3 (de)
IL (1) IL126003A0 (de)
NO (1) NO984739L (de)
PT (1) PT892802E (de)
WO (1) WO1997037992A2 (de)
ZA (1) ZA972984B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000018391A1 (en) 1998-09-30 2000-04-06 Takeda Chemical Industries, Ltd. Drugs for improving vesical excretory strength
CA2788656A1 (en) 2010-02-16 2011-08-25 Pfizer Inc. (r)-4-((4-((4-(tetrahydrofuran-3-yloxy)benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2h-pyran-4-ol, a partial agonist of 5-ht4 receptors
EP3340988B1 (de) 2015-11-12 2025-04-09 Afasci, Inc. Ionenkanalhemmende verbindungen, pharmazeutische formulierungen und verwendungen
WO2020048827A1 (en) 2018-09-03 2020-03-12 Bayer Aktiengesellschaft 1, 3, 9-triazaspiro[5.5] undecan-2-one compounds
WO2020048829A1 (en) 2018-09-03 2020-03-12 Bayer Aktiengesellschaft 3,9-diazaspiro[5.5]undecane compounds
WO2020048828A1 (en) 2018-09-03 2020-03-12 Bayer Pharma Aktiengesellschaft 5-heteroaryl-3,9-diazaspiro[5.5]undecane compounds

Also Published As

Publication number Publication date
JP2002509520A (ja) 2002-03-26
KR20000005328A (ko) 2000-01-25
AR006553A1 (es) 1999-09-08
CA2251545A1 (en) 1997-10-16
ATE252581T1 (de) 2003-11-15
EP0892802B1 (de) 2003-10-22
IL126003A0 (en) 1999-04-11
HUP9902755A2 (hu) 2000-03-28
JP3615225B2 (ja) 2005-02-02
DE69725713D1 (de) 2003-11-27
AU1990997A (en) 1997-10-29
NO984739L (no) 1998-12-09
EP0892802A1 (de) 1999-01-27
ES2207718T3 (es) 2004-06-01
KR100270145B1 (ko) 2000-11-01
CA2251545C (en) 2002-01-08
HUP9902755A3 (en) 2000-05-29
DE69725713T2 (de) 2004-05-13
WO1997037992A2 (en) 1997-10-16
NO984739D0 (no) 1998-10-09
ZA972984B (en) 1997-11-03
PT892802E (pt) 2004-03-31
BR9708563A (pt) 1999-08-03
CN1233249A (zh) 1999-10-27
AU708124B2 (en) 1999-07-29

Similar Documents

Publication Publication Date Title
NO962527D0 (no) Naftalenderivater, fremgangsmåter for deres fremstilling og mellomprodukter for dem
DK0740668T3 (da) Tetracykliske derivater, fremgangsmåde til deres fremstilling og deres anvendelse
NO980720D0 (no) Pyridazin-3-on-derivater, deres anvendelse og mellomprodukter for deres fremstilling
NO963506D0 (no) 4-Heterocyklyl-substituerte kinazolin-derivater, fremgangsmåte for fremstilling derav og deres anvendelse som anti-kreftmidler
AU6497600A (en) Peracid forming system, peracid forming composition, and methods for making and using
DK0966454T3 (da) Disubstituerede bicykliske heterocykler, deres fremstilling og deres anvendelse som lægemidler
DK0937055T3 (da) Fremgangsmåde til fremstilling af d,I-alfa-tocopherol
NO996115D0 (no) Azetidinylpropylpiperidin-derivater, intermediater og anvendelse som tachykinin-antagonister
NO990246D0 (no) Akryloylsubstituert distamycinderivater, fremgangsmÕte til fremstilling av disse, og deres anvendelse som antitumor- og antivirusmidler
DK0912509T3 (da) Distamycinderivater, fremgangsmåde til fremstilling deraf og deres anvendelse som antitumor- og antivirale midler
DK0795547T3 (da) (Aminoalkyl- og acylaminoalkyl-oxy)benzyloxyquinoliner, fremgangsmåde til deres fremstilling og deres anvendelse som bradyk
NO982708L (no) Nye fenylamidinderivater, fremgangsmÕte for fremstilling derav og deres anvendelse som legemidler
NO20010219L (no) Polycykliske tiazolidin-2-ylidenaminer, fremgangsmÕte for deres fremstilling og deres anvendelse som legemiddel
DK1015433T3 (da) Substituerede 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-oler, fremgangsmåder til fremstilling af disse og deres anvendelse som lægemidler
NO983860D0 (no) Nye triazolopuriner, fremgangsmÕte for fremstilling av dem og deres anvendelse som legemidler
DK0727416T3 (da) Substituerede benzensulfonylurinstoffer og -thiourinstoffer, og fremgangsmåde til deres fremstilling, deres anvendelse som
DK0892802T3 (da) Spiro[cyclopent[b]indol-piperidiner] og N-phenyl-hydrazon-mellemprodukter til deres fremstilling, begge som acetylcholinesterase- og mao-inhibitorer
NO951418D0 (no) Peptidderivater, deres fremstilling og anvendelse som terapeutika
DK0763535T3 (da) Piperidinylmethyloxazolidin-2-on-derivater, deres fremstilling og deres anvendelse som centralnervesystem-aktive forbindelser
DK0946579T3 (da) Nye forbindelser afledt af erythromcin, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
NO991622D0 (no) Nye derivater av pentaerytritt, deres fremstilling og anvendelse sÕvel som mellomprodukt for syntese av det samme
NO980929L (no) Nye benzoksazindionderivater, fremgangsmÕte for deres fremstilling og deres anvendelse
DK1157020T3 (da) Substituerede 1,2,3,4,5,6-hexahydro-2,6-methano-2-benzazocin-10-oler, fremgangsmåder til deres fremstilling og deres anvendelse som lægemiddel
TR199800068A3 (tr) Benzofenon türevlerinin hazirlanmasina yönelik metodlar.
DK0915076T3 (da) Fremgangsmåde til fremstilling af trans-(R,R)-actinol